日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Signaling pathways and targeted interventions for precancers

癌前病变的信号通路和靶向干预

Yang, Jin; Wang, Shimeng; Li, Xin; Xu, Hongdan; Sun, Tongxu; Hu, Tao; Luo, Jingjing; Zhou, Hongmei

Extraocular delivery of bioswitchable tri-miR-22-loaded tetrahedral DNA nanostructures for intraocular neovascular and neurodegenerative repair.

将载有生物可切换三 miR-22 的四面体 DNA 纳米结构进行眼外递送,用于眼内新生血管和神经退行性病变的修复。

Wang Qiong, Wang You, Chen Li, Huang Junyang, Cai Tao, Lin Yi, Liu Jingying, Liu Jinnan, Zhu Jiang, Li Rong, Luo Delun, Ding Xiaoyan

Androgen activity in the male embryonic hindbrain drives lethal PFA ependymoma.

雄性胚胎后脑中的雄激素活性会引发致命的 PFA 室管膜瘤。

Zhang Jiao, Ong Winnie, Rasnitsyn Alexandra, Gonzalez Ricardo Daniel, Lopez Gutierrez Rodrigo, Balin Polina, Saadeldin Amr, Wu Xiaochong, Vladoiu Maria C, Santa-Maria Lopez Vicente, Gonzalez-Salinas Fernando, Yadav Navneesh, Mohanakrishnan Dinesh, Boosi Narayana Rao Kannan, Mooli Raja Gopal Reddy, Najem Hinda, Pacheco Sebastian, Kharas Kaitlin, Richman Cory, Przelicki David, Wang Evan Y, Su Haipeng, Curry Rachel Naomi, Yang Runze, Kameda-Smith Michelle Masayo, Livingston Bryn, Scott David, Luo Zaili, Xia Mingyang, Abeysundara Namal, Erickson Anders W, Mankahla Ncedile, Hu Lucas ZhongMing, Pan Chu, Suarez Raul, Huang Ning, Wu Yihao, Wang Hao, Douglas Tajana, Pallota Jonelle, Hébert Steven, Ng Karen, Mantione Krystin, Whetstone Heather, Maan Hassaan, Lakkis Hussein, Lee Juyeun, Ramakrishnan Sadeesh K, Pei Yanxin, Tang Yujie, Lin Frank Y, Aldave Guillermo, Gallo Marco, Friedlander Robert M, Notta Faiyaz, Donovan Laura K, Chintagumpala Murali, Wang Bo, Li Yun, De Carvalho Daniel D, Zhang Zhaolei, Mao Ying, Hua Wei, Eberhart Charles, Lucas Calixto-Hope G, Venneti Sriram, Sorensen Poul H, Delaidelli Alberto, Li Hao, Zhou Wenhao, Kirk Jason, Tang Dean G, Jiang Tao, Liu Hailong, Lathia Justin D, Suzuki Hiromichi, Rich Jeremy N, Stein Lincoln D, Jabado Nada, Ramaswamy Vijay, Lu Q Richard, Heimberger Amy B, Daniels Craig, Michealraj Kulandaimanuvel Antony, Kleinman Claudia L, Taylor Michael D

Aging drives a program of DNA methylation decay in plant organs

衰老会引发植物器官中DNA甲基化水平的下降。

Dai, Dawei; Chen, Ken; Tao, Jingwen; Williams, Ben P

Creating an atlas of variant effects to resolve variants of uncertain significance and guide cardiovascular medicine

建立变异效应图谱,以解决意义未明的变异,并指导心血管医学研究。

Glazer, Andrew M; Tabet, Daniel R; Parikh, Victoria N; Kroncke, Brett M; Cote, Atina G; Yamamoto, Yuta; Wang, Qianru; Muhammad, Ayesha; Lancaster, Megan C; O'Neill, Matthew J; Weile, Jochen; Yang, Tao; Macrae, Calum A; Ashley, Euan A; Roth, Frederick P; Roden, Dan M

Hepatic adaptation to chronic metabolic stress primes tumorigenesis.

肝脏对慢性代谢应激的适应会促进肿瘤发生。

Tzouanas Constantine N, Shay Jessica E S, Sherman Marc S, Rubin Adam J, Mead Benjamin E, Dao Tyler T, Tao Junyan, Lehrich Brandon M, Eng George, Patterson-Fortin Jeffrey, Butzlaff Titus, Mana Miyeko D, Kolb Kellie E, Walesky Chad, Pepe-Mooney Brian J, Smith Colton J, Prakadan Sanjay M, Ramseier Michelle L, Tong Yuzhou Evelyn, Joung Julia, Chi Fangtao, McMahon-Skates Thomas, Winston Carolyn L, Jeong Woo-Jeong, Aney Katherine J, Chen Ethan, Nissim Sahar, Zhang Feng, Deshpande Vikram, Monga Satdarshan P, Lauer Georg M, Goessling Wolfram, Yilmaz Ömer H, Shalek Alex K

Development of a Classifier for Metabolic Subtypes of Nasopharyngeal Carcinoma to Guide Personalized Immunotherapy Strategies: Biomarker Analysis of the Phase III CONTINUUM and DIPPER Trials

开发用于指导个体化免疫治疗策略的鼻咽癌代谢亚型分类器:CONTINUUM 和 DIPPER III 期试验的生物标志物分析

Huang, Sai-Wei; Liang, Ye-Lin; Tao, Ya-Lan; Li, Wen-Fei; Zhou, Guan-Qun; Mao, Yan-Ping; Guo, Rui; Chen, Lei; Xu, Sha; Liu, Xu; Zhang, Ning; Liu, Fang; Shen, Liang-Fang; Zhou, Yang-Ying; Yuan, Ya-Wei; Zou, Guo-Rong; Jin, Feng; Tang, Ling-Long; Sun, Ying; Li, Ying-Qin; Ma, Jun; Liu, Na

Transarterial Chemoembolization Combined With Camrelizumab and Rivoceranib for Unresectable Hepatocellular Carcinoma (CHANCE2005/CARES-005): A Randomized Phase II Trial

经动脉化疗栓塞联合卡瑞利珠单抗和利沃西拉尼治疗不可切除的肝细胞癌(CHANCE2005/CARES-005):一项随机II期试验

Zhu, Hai-Dong; Fan, Wei-Jun; Zhao, Chang; Wang, Song; Li, Yu-Liang; Jin, Zhi-Cheng; Zhang, Zhe-Wei; Guo, Jin-He; Cheng, Hong-Tao; Zhang, Qi; Lu, Jian; Zeng, Yong-Yi; Lv, Wei-Fu; Xu, Hao; Shao, Hai-Bo; Xu, Wei-Guo; Zhao, Xu-Ya; Gu, Shan-Zhi; Lin, Hai-Lan; Zheng, Wen-Heng; Piao, Long-Zhen; Song, Yu-Sheng; Zhao, Jian-Bo; Wang, Yuan-Cheng; Hou, Zhi-Guo; Sun, Ying; Guan, Ni; Huang, Ming; Yang, Wei-Zhu; Ji, Jian-Song; Teng, Gao-Jun

Agent-specific, histopathology-stratified hematologic malignancy risk among dpp-4 inhibitors, glp-1 receptor agonists, and SGLT2 inhibitors: a network meta-analysis of 270,471 participants

DPP-4抑制剂、GLP-1受体激动剂和SGLT2抑制剂的药物特异性、组织病理学分层血液系统恶性肿瘤风险:一项纳入270,471名参与者的网络荟萃分析

Lin, Pao-Yen; Zeng, Bing-Syuan; Chen, Jiann-Jy; Zeng, Bing-Yan; Suen, Mein-Woei; Hung, Chao-Ming; Hsu, Chih-Wei; Stubbs, Brendon; Chen, Yen-Wen; Chen, Tien-Yu; Lei, Wei-Te; Hsu, Shih-Pin; Shiue, Yow-Ling; Su, Kuan-Pin; Li, Cheng-Ta; Wang, Hung-Yu; Tseng, Ping-Tao; Liang, Chih-Sung

CXCR4-antagonistic peptide-decorated lipid nanoparticles for co- delivery of AML1-ETO siRNA to enhance chemotherapy in refractory AML

CXCR4拮抗肽修饰的脂质纳米颗粒用于共递送AML1-ETO siRNA以增强难治性AML的化疗效果

Peng, Xuelu; Gu, Runxia; Wang, Tao; Jiang, Chuanmei; Xing, Haiyan; Meng, Jie; Wen, Tao; Liu, Jian; Wang, Jianxiang; Xu, Haiyan